We recovered compensation for volunteers who were left permanently disfigured following a drug trial at Charterhouse Clinical Research Unit.
On 18 June 1999, about 14 volunteers took part in a research trial of the drug Foscan held at the Charterhouse Clinical Research Unit in London.
Foscan is a drug being developed by Scotia Pharmaceuticals Limited for the treatment of cancer. It is a photosensitive agent, which is said to concentrate in cancerous tissue. When exposed to light the drug is activated causing it to destroy cancer cells leaving normal tissue as unaffected as possible.
The clinical trial required the participants to be injected with Foscan and to be exposed for a 15 day period to increasing amounts of artificial light. Blood tests were taken during this time.
On day 15, before being allowed home, the participants were exposed to normal daylight. If there was no adverse reaction suffered, the patients would be discharged. Thereafter, the volunteers were to avoid sunbathing and lengthy exposure to bright light for three months.
Seven of the 14 volunteers who took part in this trial instructed us to claim compensation after they suffered skin burns to the arm, which had been injected with Foscan. These burns occurred following the light exposure test performed on day 15 of the trial.
It appeared from the clients’ instructions that the trial guidelines had not been fully complied with. Scotia accepted that either this was the mechanism of injury or alternatively that there had been an extravasation of the drug.
Under guidelines governing clinical trials produced by the Association of the British Pharmaceutical Industry, Scotia were willing to pay the volunteers compensation providing they demonstrated they had suffered a significant deterioration in their health and well-being caused directly by their participation in the study.
Any disputes were to be subject to arbitration. The defendant raised arguments of contributory negligence on the part of some volunteers.
The size of burns and the nature of disfigurement suffered by volunteers varied, but it was clear that most had been left with some permanent disfigurement, which we felt was unlikely to be related to any non-compliance with guidelines by the volunteers.
Following negotiations a total compensation award of £52,600 was agreed.
- You can speak to our medical negligence solicitors on freephone 0800 358 3848
- e-Mail us at email@example.com
- Complete our short enquiry form
All enquiries are completely free of charge and we will investigate all funding options for you including no win, no fee.
Contact us on freephone 0800 358 3848
Or start your claim online.
"The group is praised for its commitment to 'demystifying the legal process' while this is a firm for which the client has always been a priority"
Fieldfisher has successfully been recognised as an "Occupation and Asbestos Disease Specialists" Fieldfisher are now recognised as assessors
Charities we support
Sepsis deaths recorded in hospitals rose by more than a third in two years
In a heart-breaking reminder of the tragedy of sepsis, William Meade's mother Melissa commented in the press this month following a report that sepsis deaths have risen by more than a third in two years.
Caron Heyes reacts to worrying report of death of twins in hospitals
An extremely concerning report from the Twins and Multiple Births Association (Tamba), commissioned by the Department of Health, has revealed that key recommendations to ensure the safety of multiple births are not being followed by many hospitals.
Fieldfisher supports family of pregnant woman who died from sepsis at Basildon Hospital
Following the inquest into the death of Reeta Saidha from sepsis at Basildon Hospital in December 2017, Iona Meeres-Young will pursue a civil claim against the hospital trust on behalf of Mrs Saidha's husband, Bhooshan, and their two daughters.
Fieldfisher attends AvMA's 30th Annual Clinical Negligence Conference
AvMA (Action against Medical Accidents) held its 30th Annual Clinical Negligence Conference on 29 and 30 June 2018.